Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Cellectar Biosciences, Inc. - Common Stock
(NQ:
CLRB
)
0.2990
+0.0158 (+5.58%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 17, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cellectar Biosciences, Inc. - Common Stock
< Previous
1
2
3
Next >
Why Is LumiraDx (LMDX) Stock Down 13% Today?
January 08, 2024
LumiraDx stock is falling hard on Monday as investors in LMDX prepare for the company's shares to be delisted on Tuesday!
Via
InvestorPlace
Why Is Cellectar Biosciences (CLRB) Stock Up 16% Today?
January 08, 2024
Cellectar Biosciences stock is up on Monday as investors celebrate positive study results with heavy trading of CLRB stock this morning.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
January 08, 2024
It's time to start the week with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Monday morning!
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's Intraday Session
September 22, 2023
Via
Benzinga
Recap: Cellectar Biosciences Q1 Earnings
May 04, 2023
Via
Benzinga
Recap: Cellectar Biosciences Q3 Earnings
November 03, 2022
Cellectar Biosciences (NASDAQ:CLRB) reported its Q3 earnings results on Thursday, November 3, 2022 at 08:30 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Cellectar Biosciences: Q2 Earnings Insights
August 05, 2022
Cellectar Biosciences (NASDAQ:CLRB) reported its Q2 earnings results on Friday, August 5, 2022 at 08:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
September 06, 2023
Via
Benzinga
Crude Oil Rises 1%; Verb Technology Shares Spike Higher
September 05, 2023
U.S. stocks traded mostly lower toward the end of trading, with the Dow Jones falling 100 points on Tuesday. The Dow traded down 0.31% to 34,728.66 while the NASDAQ rose 0.11% to 14,047.61. The S&P...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Nasdaq Turns Higher; US Factory Orders Fall 2.1% In July
September 05, 2023
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite turning higher on Tuesday. The Dow traded down 0.15% to 34,785.92 while the NASDAQ rose 0.12% to 14,048.20. The S&P 500, also...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Cellectar Biosciences Inc. (NASDAQ: CLRB) Near Top of Volume Charts in Tuesday Trading
September 05, 2023
Via
Investor Brand Network
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
September 05, 2023
Via
Benzinga
Why America's Car-Mart Are Trading Lower By 12%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
September 05, 2023
Gainers Verb Technology Company, Inc. (NASDAQ: VERB) shares jumped 164% to $1.89 after the completed and launched a technology integration and strategic relationship with global social media platform...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
March 01, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
August 23, 2022
Via
Benzinga
Why Zoom Video Is Trading Lower By 11%; Here Are 28 Stocks Moving Premarket
August 23, 2022
Gainers Quotient Limited (NASDAQ: QTNT) shares rose 58.2% to $0.3070 in pre-market trading. Quotient recently reported a wider Q1 loss.
Via
Benzinga
Why Energy Stocks Traded Higher; Here Are 61 Biggest Movers From Yesterday
July 26, 2022
Gainers GeoVax Labs, Inc. (NASDAQ: GOVX) jumped 150.4% to close at $1.59 on Monday after declining 8% on Friday.
Via
Benzinga
Why Is Infrastructure and Energy Alternatives Higher By Around 29%? 37 Stocks Moving In Monday's Mid-Day Session
July 25, 2022
Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) jumped 104% to $1.3263 after the company announced that primary endpoint was met in study for its treatment of allergic rhinitis.
Via
Benzinga
Daily Biotech Pulse: VistaGen's Anxiety Study Fails, Silverback To Merge With Firm Developing EpiPen Alternative, Setback For Liminal's Lead Asset
July 22, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
July 21, 2022
Gainers Hanger (NYSE:HNGR) stock moved upwards by 27.1% to $18.75 during Thursday's after-market session. The company's market cap stands at $731.7 million.
Via
Benzinga
Why Is United Airlines Down By Over 6%? Here Are 25 Stocks Moving In Thursday's Pre-Market Session
July 21, 2022
Gainers Tuesday Morning Corporation (NASDAQ: TUEM) rose 72.1% to $0.3420 in pre-market trading after dipping 30% on Wednesday. Tuesday Morning recently announced partnership with Intalytics for...
Via
Benzinga
Why Baker Hughes Shares Dropped 8%; Here Are 64 Biggest Movers From Yesterday
July 21, 2022
Gainers Pagaya Technologies Ltd. (NASDAQ: PGY) shares climbed 129.6% to close at $6.20 on Wednesday. Pagaya Technologies is expected to announce its Q2 earnings on August 16, 2022.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
July 20, 2022
Via
Benzinga
Recap: Cellectar Biosciences Q1 Earnings
May 10, 2022
Cellectar Biosciences (NASDAQ:CLRB) reported its Q1 earnings results on Tuesday, May 10, 2022 at 08:00 AM. Here's what investors need to know about the announcement. Earnings Cellectar Biosciences...
Via
Benzinga
51 Biggest Movers From Thursday
April 18, 2022
Gainers MedAvail Holdings, Inc. (NASDAQ: MDVL) shares surged 69.4% to close at $2.44 on Thursday. Ally Bridge Group recently reported a purchase of 21.176 million shares of...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
April 14, 2022
Gainers
Via
Benzinga
Here's Why Cellectar Biosciences Shares Are Rising
March 21, 2022
Cellectar Biosciences Inc (NASDAQ: CLRB) shares are trading higher by 12.1% at $0.61 after the company reported better-than-expected fourth-quarter EPS results. Cellectar Biosciences beat estimated...
Via
Benzinga
Recap: Cellectar Biosciences Q4 Earnings
March 21, 2022
Cellectar Biosciences (NASDAQ:CLRB) reported its Q4 earnings results on Monday, March 21, 2022 at 08:30 AM. Here's what investors need to know about the announcement....
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
February 07, 2022
Gainers Agile Therapeutics (NASDAQ:AGRX) ...
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
January 28, 2022
Gainers Enveric Biosciences (NASDAQ:ENVB)...
Via
Benzinga
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.